In a study by Chiodino et al., the presence of survivin in more aggressive and poorly differentiated variants of oral SCC confirmed and extended earlier reports of survivin expression in cancers and suggested its potential predictive and prognostic impact for disease progression [18]. This evidence concerns the gene BIRC5 and cancer.